In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.

British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...

"Aging has a relatively simple explanation and is apparently reversible." The post Scientists Testing Controversial Human ...

IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic ...

Scientists discover how aging alters the function of cells, called mesenchymal drift, and manage to reverse this process.

For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...

From high-tech biohacking to holistic wellness: in the race to live forever, who’s benefitting from the science of longevity?

Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...

Scientists at Life Biosciences are testing a controversial compound, ER-100, aimed at reversing human aging by resetting cells.